Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06417489
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-11
Brief Title:
Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients
Sponsor:
Peking University First Hospital
Organization:
Peking University First Hospital
Organization Data
Organization:
Peking University First Hospital
Class:
OTHER
Study ID:
2024-165-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University First Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None